J. Ong

M. Buti, M. Zheng, M. Stepanova, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.

M. Stepanova, L. Henry, Z. Younossi, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.

V. Wong, V. de Lédinghen, M. Stepanova, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Editorial: probiotics in NASH – more studies are needed

Z. Younossi, J. Ong, Z. Younossi, 2014, Alimentary pharmacology & therapeutics.

Patent ductus venosus in an adult presenting as pulmonary hypertension, right side heart failure and portosystemic encephalopathy

B. Dolmatch, Z. Younossi, B. Shen, 2000, American Journal of Gastroenterology.

Ursodeoxycholic Acid in the Prevention of Gallstone Formation after Bariatric Surgery: A Meta-analysis

Wendell Z. Espinosa, J. Ong, M. L. Daez, 2008, Obesity surgery.

Selective Digestive Decontamination and its Use in Patients with Liver Disease

Z. Younossi, J. Ong, 1998 .

Outcomes of patients with non-alcoholic fatty liver disease

M. Stepanova, Z. Younossi, J. Ong, 2009 .

A. Baranova, Z. Younossi, K. Schlauch, 2005, Obesity surgery.

Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C.

Z. Goodman, Z. Younossi, T. Gramlich, 2001, Transplantation.

329 THE IMPACT OF FATIGUE ON PATIENT-REPORTED OUTCOMES (PRO) IN PATIENTS WITH CHRONIC LIVER DISEASE (CLD): DATA FROM THE GLOBAL LIVER REGISTRY (GLR)

S. Hamid, M. Stepanova, Y. Eguchi, 2020 .

Editorial: Non-Alcoholic Fatty Liver Disease After Liver Transplantation: A Case of Nurture and Nature

Z. Younossi, J. Ong, 2010, The American Journal of Gastroenterology.

Challenges of designing hepatic encephalopathy treatment trials

K. Mullen, M. Sanaka, J. Ong, 2003, Hepatology.

Antibody response to Engerix‐B® and Recombivax‐HB® hepatitis B vaccination in end‐stage renal disease

J. Lazarus, E. Lacson, N. Ofsthun, 2005, Hemodialysis international. International Symposium on Home Hemodialysis.

Noradrenaline vs Terlipressin for Hepatorenal Syndrome (No To Hepatorenal Syndrome): A Meta-Analysis

J. Ong, Jezreel L Taquiso, Farrah Haidee, 2015 .

Correlation between ammonia levels and the severity of hepatic encephalopathy.

Frederick Van Lente, D. Krieger, A. Arroliga, 2003, The American journal of medicine.

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

V. Wong, F. Negro, M. Stepanova, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Advancing the global public health agenda for NAFLD: a consensus statement

Myeong Jun Song, R. Malekzadeh, V. Wong, 2021, Nature Reviews Gastroenterology & Hepatology.

Hepatic gene expression in patients with obesity‐related non‐alcoholic steatohepatitis

Z. Goodman, Z. Younossi, K. Schlauch, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis B infection among adults in the philippines: A national seroprevalence study.

J. Sollano, J. Ong, Stephen N. Wong, 2013, World journal of hepatology.

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease.

Z. Younossi, T. Gramlich, J. Ong, 2001, Liver.

Hepatology Society of the Philippines

D. Payawal, J. Sollano, Judy Lao-Tan, 2008 .

Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin

J. Hoofnagle, J. Everhart, D. Kleiner, 2003, Hepatology.

A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease

A. Baranova, Z. Goodman, Z. Younossi, 2005, Hepatology.

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.

Jisoo A. Kwon, V. Wong, F. Tacke, 2022, The lancet. Gastroenterology & hepatology.

Transjugular intrahepatic portosystemic shunts (TIPS): a decade later.

Z. Younossi, M. Sands, J P Ong, 2000, Journal of clinical gastroenterology.

Gene Expression of Leptin, Resistin, and Adiponectin in the White Adipose Tissue of Obese Patients with Non-Alcoholic Fatty Liver Disease and Insulin Resistance

Karen Schlauch, Ancha Baranova, A. Baranova, 2006, Obesity surgery.

Correlation Between Ammonia Levels and the Severity of Hepatic Encephalopathy

D. Krieger, F. V. Lente, A. Arroliga, 2004 .

SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

V. Gebski, K. Soo, C. Thng, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Predictors of Large Esophageal Varices: How Accurate Are They?

Z. Younossi, J. Ong, 1999, American Journal of Gastroenterology.

Epidemiology and natural history of NAFLD and NASH.

Z. Younossi, J. Ong, 2007, Clinics in liver disease.

Non‐alcoholic fatty liver disease: An overview

Z. Younossi, B. Mulhall, Janus P Ong, 2002, Journal of gastroenterology and hepatology.

Liver Diseases: perspective from the Philippines.

J. Ong, E. Ornos, Karl Jeffrey E. Murillo, 2023, Annals of hepatology.

Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region.

J. Ong, K. Alswat, M. El-Kassas, 2023, Clinics in liver disease.

Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large‐scale Asian study

R. Mohamed, T. Tanwandee, H. Chan, 2021, Journal of viral hepatitis.

Oral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy

Z. Younossi, J. Ong, G. Oehler, 2011, Clinical drug investigation.

Demographic Profile and Treatment Outcomes of Filipino Patients With Hepatocellular Carcinoma in a Liver Tumor Registry

J. Ong, Ivonne Vicente, G. Carpio, 2014 .

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

Z. Younossi, T. Gramlich, J. Ong, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia.

Z. Younossi, J. Ong, 2004, Cleveland Clinic journal of medicine.

Clinical and Patient Reported Outcomes from Patients with Non-alcoholic Fatty Liver Disease Across the World: Data from the Global NASH/NAFLD Registry.

M. Stepanova, Y. Eguchi, A. Duseja, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™

M. Buti, S. Hamid, M. Stepanova, 2023, Journal of viral hepatitis.

Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C

Z. Younossi, A. McCullough, A. Tavill, 2004, Journal of clinical gastroenterology.

The Impact of NASH to Liver Transplantations with Hepatocellular Carcinoma in the United States.

M. Stepanova, Z. Younossi, Y. Younossi, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Severe impairment of patient‐reported outcomes in patients with chronic hepatitis C virus infection seen in real‐world practices across the world: Data from the global liver registry

M. Buti, S. Hamid, M. Stepanova, 2022, Journal of viral hepatitis.

The Clinical Profile of Hepatocellular Carcinoma Patients at the Philippine General Hospital

J. Ong, Perpetua C Patal, Z. Lucas, 2009 .

Stigma in NAFLD and NASH: a global survey of patients and providers

V. Wong, K. Cusi, T. Kawaguchi, 2023, Journal of Hepatology.

Outcome of De Novo Hepatitis C Virus Infection in Heart Transplant Recipients

Lieberman, M. Goormastic, R. Starling, 1999 .

Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU.

A. Arroliga, Z. Younossi, D. Nelson, 2001, Chest.

A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment

Z. Younossi, M. Srishord, J. Ong, 2008, Journal of viral hepatitis.

Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients

Z. Goodman, Z. Younossi, H. Reines, 2005 .

Nonalcoholic fatty liver disease and the epidemic of obesity.

Z. Younossi, J. Ong, R. Collantes, 2004, Cleveland Clinic journal of medicine.

Prevalence and Risk Factors of Hepatitis B Infection in Pregnant Women at the Prenatal Clinic of The University of the Philippines – Philippine General Hospital

J. Ong, L. Tan, M. L. Daez, 2015 .

Prevalence and risk factors of hepatitis B infection in pregnant women at the prenatal clinic of the University of the Philippines-Philippine General Hospital

J. Ong, L. Tan, M. L. Daez, 2015 .

The portrait of adult liver transplant recipients in the United States from 2002 to 2020

M. Stepanova, L. Henry, Z. Younossi, 2022, Journal of Hepatology.

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.

Jisoo A. Kwon, R. Malekzadeh, F. Tacke, 2023, The lancet. Gastroenterology & hepatology.

Halfway through HBV elimination - are we not waiting?

J. Ong, Apichat Kaewdech, Grace Lai-Hung Wong, 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Predictors of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Morbidly Obese Patients

Z. Goodman, Z. Younossi, H. Reines, 2005, Obesity surgery.

The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019

Z. Younossi, J. Ong, James M. Paik, 2023, Hepatology communications.

Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?

Z. Younossi, J. Ong, 2002, Gastroenterology.

Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.

M. Stepanova, Z. Younossi, J. Ong, 2024, Journal of hepatology.

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.

M. Stepanova, A. Duseja, Z. Younossi, 2023, Journal of hepatology.

The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction–associated steatotic liver disease and alcohol-associated liver disease

M. Stepanova, Z. Younossi, J. Ong, 2023, Hepatology communications.